Articles: sars-cov-2.
-
In South Africa (SA), >2.4 million cases of COVID‑19 and >72 000 deaths were recorded between March 2020 and 1 August 2021, affecting the country's 52 districts to various extents. SA has committed to a COVID‑19 vaccine roll-out in three phases, prioritising frontline workers, the elderly, people with comorbidities and essential workers. However, additional actions will be necessary to support efficient allocation and equitable access for vulnerable, access-constrained communities. ⋯ The end goal is to provide equal distribution of vaccines proportional to district populations, which will provide fair protection. Districts with a high risk of resurgence and severity should be prioritised for vaccine roll-out, particularly the major metropolitan areas. We provide recommendations for allocations of different vaccine types for each district that consider levels of access, numbers of doses and cold-chain storage capability.
-
COVID-19 has been reported to affect a variety of organs. We report a case of constrictive pericarditis in a patient who had contracted the SARS-CoV-2 virus. Other possible causes such as tuberculosis and metabolic causes were considered, but excluded by special investigations.
-
Dtsch. Med. Wochenschr. · Feb 2022
Case Reports[Late neurological consequences of a SARS-CoV-2 infection].
Persistent neurological late symptoms of SARS-CoV-2 infection are common and require regular follow-up treatment. In order to establish uniform therapy concepts, it is necessary to evaluate individual therapeutic approaches for long COVID and post-COVID-19 syndrome. ⋯ Whole body and brain FDG PET can be helpful in long COVID and post-COVID-19 syndrome patients with neurological symptoms of unknown origin. These patients benefit from systematic rehabilitation. Glucocorticoids and colchicine appear to accelerate symptom reduction. The rehabilitative therapy should be continued on an outpatient basis.
-
For initial cognitive diagnostics in the practice, various screening tools in the form of short paper-pencil-tests are available. Such initial screenings take between 5 and 15 minutes, but do not replace detailed neuropsychological diagnostics. Of the screening-tools reviewed, DemTect is suitable for suspected early onset dementia, while MMSE and MoCA cover other cognitive domains in greater detail. ⋯ A more comprehensive diagnosis of dementia is not possible with the screening tools reviewed. However, they can help to decide whether a detailed dementia analysis is necessary or whether one can wait with it. The screening methods reviewed are freely available on the internet.